Literature DB >> 19529981

Synergistic protecting effect of cord blood CD34+ cells over-expressing both interleukin-3 and Flt3 ligand on lethally irradiated mice.

Yong Zhang1, Chaohua Guo2, Hongbin Zhang3, Shiwu Dong2.   

Abstract

The objective of the present work was to study the effect of interleukin-3 (IL-3) and Flt3 ligand (FL) over-expression in human cord blood CD34(+) cells on rescuing lethally irradiated mice by transplantation. CD34(+) cells were isolated from human umbilical cord blood (UCB) and infected with recombinant retrovirus expressing FL, IL-3 or FL/IL-3 genes, respectively. Stably transduced CD34(+) cells were transplanted i.v. into NOD/SCID/IL2rgamma(null) mice that had been conditioned with 8.0 Gy of irradiation. At 6 weeks post-irradiation, chimerism in the animal bone marrow (BM) and the spleen were investigated. Recovery of peripheral blood cell and animal survival were recorded 2, 4, and 6 weeks post-irradiation. The chimerism was further investigated by serial transplantation assay. At 6 weeks post-transplantation, each of the three transduced human UCB CD34(+) cell types could be observed in all examined BM of chimeric mice; however, more human cells could be found in BM, spleen and peripheral blood of those mice transplanted with CD34(+) cells over-expressing IL-3/FL cells. Over-expression of IL-3 and FL at mRNA and protein levels could be detected in the BM cells of chimeric mice. Accordingly, hIL-3/FL co-overexpressing mice showed greater recovery of peripheral blood counts as early as 2 weeks after irradiation, and a much higher survival rate (11/12) than other groups at 6 weeks post-irradiation. Serial transplantation assay indicated that human cord blood CD34(+) cells could recover potentials of proliferation and self-renewal after being transplanted into mice. Our results suggested that transplant of CD34(+) cord blood cells over-expressing IL-3/FL genes improved rescue of radiation-injured mice, which probably results from the synergistic effect between hIL-3 and hFL causing the rapid reconstitution of hematopoiesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19529981     DOI: 10.1007/s12185-009-0348-8

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  31 in total

1.  Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates.

Authors:  Steven M Devine; Carrington Cobbs; Matt Jennings; Amelia Bartholomew; Ron Hoffman
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

Review 2.  Cytokine-based treatment of accidentally irradiated victims and new approaches.

Authors:  Francis Hérodin; Michel Drouet
Journal:  Exp Hematol       Date:  2005-10       Impact factor: 3.084

Review 3.  Umbilical cord blood transplantation for myeloid malignancies.

Authors:  Claudio G Brunstein; K Scott Baker; John E Wagner
Journal:  Curr Opin Hematol       Date:  2007-03       Impact factor: 3.284

Review 4.  Alternative donor transplantation in acute myeloid leukemia: which source and when?

Authors:  Tsila Zuckerman; Jacob M Rowe
Journal:  Curr Opin Hematol       Date:  2007-03       Impact factor: 3.284

Review 5.  Radioprotection with cytokines--learning from nature to cope with radiation damage.

Authors:  R Neta; J J Oppenheim
Journal:  Cancer Cells       Date:  1991-10

6.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Authors:  M J Laughlin; J Barker; B Bambach; O N Koc; D A Rizzieri; J E Wagner; S L Gerson; H M Lazarus; M Cairo; C E Stevens; P Rubinstein; J Kurtzberg
Journal:  N Engl J Med       Date:  2001-06-14       Impact factor: 91.245

7.  Radioprotection of mice by recombinant rat stem cell factor.

Authors:  K M Zsebo; K A Smith; C A Hartley; M Greenblatt; K Cooke; W Rich; I K McNiece
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

8.  Medical management of the acute radiation syndrome: recommendations of the Strategic National Stockpile Radiation Working Group.

Authors:  Jamie K Waselenko; Thomas J MacVittie; William F Blakely; Nicki Pesik; Albert L Wiley; William E Dickerson; Horace Tsu; Dennis L Confer; C Norman Coleman; Thomas Seed; Patrick Lowry; James O Armitage; Nicholas Dainiak
Journal:  Ann Intern Med       Date:  2004-06-15       Impact factor: 25.391

9.  Interactions among colony-stimulating factors, IL-1 beta, IL-6, and kit-ligand in the regulation of primitive murine hematopoietic cells.

Authors:  M O Muench; J G Schneider; M A Moore
Journal:  Exp Hematol       Date:  1992-03       Impact factor: 3.084

10.  Crucial role of FLT3 ligand in immune reconstitution after bone marrow transplantation and high-dose chemotherapy.

Authors:  Natalija Buza-Vidas; Min Cheng; Sara Duarte; Hojjatollah Nozad; Sten Eirik W Jacobsen; Ewa Sitnicka
Journal:  Blood       Date:  2007-03-22       Impact factor: 22.113

View more
  3 in total

1.  Co-transplantation with mesenchymal stem cells expressing a SDF-1/HOXB4 fusion protein markedly improves hematopoietic stem cell engraftment and hematogenesis in irradiated mice.

Authors:  Tingting Chen; Pei Zhang; Wenxia Fan; Fenghua Qian; Li Pei; Shuangnian Xu; Zhongmin Zou; Bing Ni; Yong Zhang
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

2.  Optimization of adipose tissue-derived mesenchymal stromal cells transplantation for bone marrow repopulation following irradiation.

Authors:  Min-Jung Kim; Won Moon; Jeonghoon Heo; Sangwook Lim; Seung-Hyun Lee; Jee-Yeong Jeong; Sang Joon Lee
Journal:  World J Stem Cells       Date:  2022-03-26       Impact factor: 5.326

3.  Follow-up study of abnormal biological indicators and gene expression in the peripheral blood of three accidentally exposed persons.

Authors:  Cuiping Chi; Rong Tian; Huifang Liu; Haiyan Wang; Jinping Wei; Jianping Guo; Fengling Guo; Shufang Li
Journal:  J Radiat Res       Date:  2013-04-04       Impact factor: 2.724

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.